Evaluation of Telemedicine Medical Abortion Service in Ecuador
ConditionPregnancy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age15+
SponsorGynuity Health Projects
About this trial
This research seeks to demonstrate that a telemedicine model for the provision of legal abortion services in Ecuador is safe, feasible and acceptable to users requesting a medication abortion and who are less than 12 weeks pregnant.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Woman is seeking abortion care and wants to use telemedicine service for her medication abortion procedure.
Woman has access to an internet connection or a device that allows remote consultation.
Woman is 15 years of age or older.
Woman can provide an address to which abortion medications will be mailed.
Disqualifiers
Medically ineligible for procedure.
Provider determines that a medical abortion using the telemedicine approach is not appropriate for that person.
Trial population
Women seeking abortion
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Misoprostol
DrugSelf-administered misoprostol by clients obtaining medication abortion via telemedicine
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: early medication abortion via telemedicine1 intervention
Trial outcomes
Primary outcomes
1
Adverse events (safety)
Incidence of adverse events among those who self-administered medication abortion regimen
Time frame
6 weeksSecondary outcomes
1
Feasibility of telemedicine service
Number of reported difficulties related to adhering to requirements of the protocol.
Time frame
6 weeks2
Acceptability of telemedicine service
Reported satisfaction levels among participants (very satisfied, satisfied, unsatisfied, very unsatisfied).
Time frame
6 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov